Tirzepatide
TIRZE-PAP
Eli Lilly · Phase 2/3 · Not yet recruiting · Enrollment 256
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Continuous Positive Airway Pressure (CPAP) | Obesity or overweight | n/r | 4 | n/r | n/r |
| Tirzepatide | Obesity or overweight | n/r | 4 | n/r | n/r |